Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intercenter reproducibility of binary typing for Staphylococcus aureus.
van Leeuwen WB, Snoeijers S, van der Werken-Libregts C, Tuip A, van der Zee A, Egberink D, de Proost M, Bik E, Lunter B, Kluytmans J, Gits E, van Duyn I, Heck M, van der Zwaluw K, Wannet W, Noordhoek GT, Mulder S, Renders N, Boers M, Zaat S, van der Riet D, Kooistra M, Talens A, Dijkshoorn L, van der Reyden T, Veenendaal D, Bakker N, Cookson B, Lynch A, Witte W, Cuny C, Blanc D, Vernez I, Hryniewicz W, Fiett J, Struelens M, Deplano A, Landegent J, Verbrugh HA, van Belkum A. van Leeuwen WB, et al. Among authors: bakker n. J Microbiol Methods. 2002 Sep;51(1):19-28. doi: 10.1016/s0167-7012(02)00049-0. J Microbiol Methods. 2002. PMID: 12069886
New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases.
van Noorden CJF, Yetkin-Arik B, Serrano Martinez P, Bakker N, van Breest Smallenburg ME, Schlingemann RO, Klaassen I, Majc B, Habic A, Bogataj U, Galun SK, Vittori M, Erdani Kreft M, Novak M, Breznik B, Hira VVV. van Noorden CJF, et al. Among authors: bakker n. J Histochem Cytochem. 2024 May;72(5):329-352. doi: 10.1369/00221554241249515. Epub 2024 May 11. J Histochem Cytochem. 2024. PMID: 38733294 Free PMC article. Review.
PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma.
Pour L, Micheva I, Usenko G, Mikala G, Masszi T, Simeonova K, Thuresson M, Huledal G, Norin S, Bakker NA, Minarik J. Pour L, et al. Among authors: bakker na. Clin Lymphoma Myeloma Leuk. 2024 Jun;24(6):e267-e275.e2. doi: 10.1016/j.clml.2024.02.012. Epub 2024 Feb 23. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38490927 Free article. Clinical Trial.
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.
Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P. Schjesvold FH, et al. Among authors: bakker na. Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.284635. Online ahead of print. Haematologica. 2024. PMID: 38426292 Free article.
206 results